Come up with a name for your new list and we'll add to it:
Clover Therapeutics raised a round of funding on July 21, 2017. Investors include
Premio Gaetano Marzotto.
Clover Therapeutics is developing a technology platform based on drug delivery and biomimicry, whose first application will be in the urological oncology field, specifically against Bladder Cancer.…